Loading…
Noxa upregulation by oncogenic activation of MEK/ERK through CREB promotes autophagy in human melanoma cells
Reduction in the expression of the anti-survival BH3-only proteins PUMA and Bim is associated with the pathogenesis of melanoma. However, we have found that the expression of the other BH3-only protein Noxa is commonly upregulated in melanoma cells, and that this is driven by oncogenic activation of...
Saved in:
Published in: | Oncotarget 2014-11, Vol.5 (22), p.11237-11251 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c462t-80b98b6699cc5427b9eb8ea087decc2fe34c1874ef6553b0cfc55738ae9bc0b73 |
---|---|
cites | cdi_FETCH-LOGICAL-c462t-80b98b6699cc5427b9eb8ea087decc2fe34c1874ef6553b0cfc55738ae9bc0b73 |
container_end_page | 11251 |
container_issue | 22 |
container_start_page | 11237 |
container_title | Oncotarget |
container_volume | 5 |
creator | Liu, Yi Lun Lai, Fritz Wilmott, James S Yan, Xu Guang Liu, Xiao Ying Luan, Qi Guo, Su Tang Jiang, Chen Chen Tseng, Hsin-Yi Scolyer, Richard A Jin, Lei Zhang, Xu Dong |
description | Reduction in the expression of the anti-survival BH3-only proteins PUMA and Bim is associated with the pathogenesis of melanoma. However, we have found that the expression of the other BH3-only protein Noxa is commonly upregulated in melanoma cells, and that this is driven by oncogenic activation of MEK/ERK. Immunohistochemistry studies showed that Noxa was expressed at higher levels in melanomas than nevi. Moreover, the expression of Noxa was increased in metastatic compared to primary melanomas, and in thick primaries compared to thin primaries. Inhibition of oncogenic BRAFV600E or MEK downregulated Noxa, whereas activation of MEK/ERK caused its upregulation. In addition, introduction of BRAFV600E increased Noxa expression in melanocytes. Upregulation of Noxa was due to a transcriptional increase mediated by cAMP responsive element binding protein, activation of which was also increased by MEK/ERK signaling in melanoma cells. Significantly, Noxa appeared necessary for constitutive activation of autophagy, albeit at low levels, by MEK/ERK in melanoma cells. Furthermore, it was required for autophagy activation that delayed apoptosis in melanoma cells undergoing nutrient deprivation. These results reveal that oncogenic activation of MEK/ERK drives Noxa expression to promote autophagy, and suggest that Noxa has an indirect anti-apoptosis role in melanoma cells under nutrient starvation conditions. |
doi_str_mv | 10.18632/oncotarget.2616 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4294377</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1639496843</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-80b98b6699cc5427b9eb8ea087decc2fe34c1874ef6553b0cfc55738ae9bc0b73</originalsourceid><addsrcrecordid>eNpVUUtP3DAQtlARIODeU-VjLwuO7Tj2pVK72ha0QCXUni3bTB5VYqe2g7r_vll2ec1lRvP4Zr75EPpYkItCCkYvg3chm9hAvqCiEAfopFBcLWhZsg9v4mN0ntIfMlvJK0nVETqmJRMlqeQJ6u_CP4OnMUIz9SZ3wWO7wVvkBnznsHG5e9zlQ41vV-vL1f0a5zaGqWnx8n71DY8xDCFDwmbKYWxNs8Gdx-00GI8H6I0Pg8EO-j6docPa9AnO9_4U_f6--rW8Wtz8_HG9_HqzcFzQvJDEKmmFUMq5ktPKKrASDJHVAzhHa2DcFbLiUIuZniWudmVZMWlAWUdsxU7Rlx3uONkBHhz4HE2vx9gNJm50MJ1-X_Fdq5vwqDlVnFVbgM97gBj-TpCyHrq0pWA8hCnpQrD5u0JyNreSXauLIaUI9cuagugnnfSrTnqr0zzy6e15LwPPqrD_nQKUDg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1639496843</pqid></control><display><type>article</type><title>Noxa upregulation by oncogenic activation of MEK/ERK through CREB promotes autophagy in human melanoma cells</title><source>PubMed Central (PMC)</source><creator>Liu, Yi Lun ; Lai, Fritz ; Wilmott, James S ; Yan, Xu Guang ; Liu, Xiao Ying ; Luan, Qi ; Guo, Su Tang ; Jiang, Chen Chen ; Tseng, Hsin-Yi ; Scolyer, Richard A ; Jin, Lei ; Zhang, Xu Dong</creator><creatorcontrib>Liu, Yi Lun ; Lai, Fritz ; Wilmott, James S ; Yan, Xu Guang ; Liu, Xiao Ying ; Luan, Qi ; Guo, Su Tang ; Jiang, Chen Chen ; Tseng, Hsin-Yi ; Scolyer, Richard A ; Jin, Lei ; Zhang, Xu Dong</creatorcontrib><description>Reduction in the expression of the anti-survival BH3-only proteins PUMA and Bim is associated with the pathogenesis of melanoma. However, we have found that the expression of the other BH3-only protein Noxa is commonly upregulated in melanoma cells, and that this is driven by oncogenic activation of MEK/ERK. Immunohistochemistry studies showed that Noxa was expressed at higher levels in melanomas than nevi. Moreover, the expression of Noxa was increased in metastatic compared to primary melanomas, and in thick primaries compared to thin primaries. Inhibition of oncogenic BRAFV600E or MEK downregulated Noxa, whereas activation of MEK/ERK caused its upregulation. In addition, introduction of BRAFV600E increased Noxa expression in melanocytes. Upregulation of Noxa was due to a transcriptional increase mediated by cAMP responsive element binding protein, activation of which was also increased by MEK/ERK signaling in melanoma cells. Significantly, Noxa appeared necessary for constitutive activation of autophagy, albeit at low levels, by MEK/ERK in melanoma cells. Furthermore, it was required for autophagy activation that delayed apoptosis in melanoma cells undergoing nutrient deprivation. These results reveal that oncogenic activation of MEK/ERK drives Noxa expression to promote autophagy, and suggest that Noxa has an indirect anti-apoptosis role in melanoma cells under nutrient starvation conditions.</description><identifier>ISSN: 1949-2553</identifier><identifier>EISSN: 1949-2553</identifier><identifier>DOI: 10.18632/oncotarget.2616</identifier><identifier>PMID: 25365078</identifier><language>eng</language><publisher>United States: Impact Journals LLC</publisher><subject>Autophagy - physiology ; Cell Line, Tumor ; Extracellular Signal-Regulated MAP Kinases - genetics ; Extracellular Signal-Regulated MAP Kinases - metabolism ; Humans ; MAP Kinase Kinase Kinases - genetics ; MAP Kinase Kinase Kinases - metabolism ; MAP Kinase Signaling System ; Melanocytes - enzymology ; Melanocytes - metabolism ; Melanocytes - pathology ; Melanoma - enzymology ; Melanoma - genetics ; Melanoma - metabolism ; Melanoma - pathology ; Proto-Oncogene Proteins c-bcl-2 - genetics ; Proto-Oncogene Proteins c-bcl-2 - metabolism ; Research Paper ; Signal Transduction ; Up-Regulation</subject><ispartof>Oncotarget, 2014-11, Vol.5 (22), p.11237-11251</ispartof><rights>Copyright: © 2014 Liu et al. 2014</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-80b98b6699cc5427b9eb8ea087decc2fe34c1874ef6553b0cfc55738ae9bc0b73</citedby><cites>FETCH-LOGICAL-c462t-80b98b6699cc5427b9eb8ea087decc2fe34c1874ef6553b0cfc55738ae9bc0b73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294377/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294377/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27922,27923,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25365078$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Yi Lun</creatorcontrib><creatorcontrib>Lai, Fritz</creatorcontrib><creatorcontrib>Wilmott, James S</creatorcontrib><creatorcontrib>Yan, Xu Guang</creatorcontrib><creatorcontrib>Liu, Xiao Ying</creatorcontrib><creatorcontrib>Luan, Qi</creatorcontrib><creatorcontrib>Guo, Su Tang</creatorcontrib><creatorcontrib>Jiang, Chen Chen</creatorcontrib><creatorcontrib>Tseng, Hsin-Yi</creatorcontrib><creatorcontrib>Scolyer, Richard A</creatorcontrib><creatorcontrib>Jin, Lei</creatorcontrib><creatorcontrib>Zhang, Xu Dong</creatorcontrib><title>Noxa upregulation by oncogenic activation of MEK/ERK through CREB promotes autophagy in human melanoma cells</title><title>Oncotarget</title><addtitle>Oncotarget</addtitle><description>Reduction in the expression of the anti-survival BH3-only proteins PUMA and Bim is associated with the pathogenesis of melanoma. However, we have found that the expression of the other BH3-only protein Noxa is commonly upregulated in melanoma cells, and that this is driven by oncogenic activation of MEK/ERK. Immunohistochemistry studies showed that Noxa was expressed at higher levels in melanomas than nevi. Moreover, the expression of Noxa was increased in metastatic compared to primary melanomas, and in thick primaries compared to thin primaries. Inhibition of oncogenic BRAFV600E or MEK downregulated Noxa, whereas activation of MEK/ERK caused its upregulation. In addition, introduction of BRAFV600E increased Noxa expression in melanocytes. Upregulation of Noxa was due to a transcriptional increase mediated by cAMP responsive element binding protein, activation of which was also increased by MEK/ERK signaling in melanoma cells. Significantly, Noxa appeared necessary for constitutive activation of autophagy, albeit at low levels, by MEK/ERK in melanoma cells. Furthermore, it was required for autophagy activation that delayed apoptosis in melanoma cells undergoing nutrient deprivation. These results reveal that oncogenic activation of MEK/ERK drives Noxa expression to promote autophagy, and suggest that Noxa has an indirect anti-apoptosis role in melanoma cells under nutrient starvation conditions.</description><subject>Autophagy - physiology</subject><subject>Cell Line, Tumor</subject><subject>Extracellular Signal-Regulated MAP Kinases - genetics</subject><subject>Extracellular Signal-Regulated MAP Kinases - metabolism</subject><subject>Humans</subject><subject>MAP Kinase Kinase Kinases - genetics</subject><subject>MAP Kinase Kinase Kinases - metabolism</subject><subject>MAP Kinase Signaling System</subject><subject>Melanocytes - enzymology</subject><subject>Melanocytes - metabolism</subject><subject>Melanocytes - pathology</subject><subject>Melanoma - enzymology</subject><subject>Melanoma - genetics</subject><subject>Melanoma - metabolism</subject><subject>Melanoma - pathology</subject><subject>Proto-Oncogene Proteins c-bcl-2 - genetics</subject><subject>Proto-Oncogene Proteins c-bcl-2 - metabolism</subject><subject>Research Paper</subject><subject>Signal Transduction</subject><subject>Up-Regulation</subject><issn>1949-2553</issn><issn>1949-2553</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNpVUUtP3DAQtlARIODeU-VjLwuO7Tj2pVK72ha0QCXUni3bTB5VYqe2g7r_vll2ec1lRvP4Zr75EPpYkItCCkYvg3chm9hAvqCiEAfopFBcLWhZsg9v4mN0ntIfMlvJK0nVETqmJRMlqeQJ6u_CP4OnMUIz9SZ3wWO7wVvkBnznsHG5e9zlQ41vV-vL1f0a5zaGqWnx8n71DY8xDCFDwmbKYWxNs8Gdx-00GI8H6I0Pg8EO-j6docPa9AnO9_4U_f6--rW8Wtz8_HG9_HqzcFzQvJDEKmmFUMq5ktPKKrASDJHVAzhHa2DcFbLiUIuZniWudmVZMWlAWUdsxU7Rlx3uONkBHhz4HE2vx9gNJm50MJ1-X_Fdq5vwqDlVnFVbgM97gBj-TpCyHrq0pWA8hCnpQrD5u0JyNreSXauLIaUI9cuagugnnfSrTnqr0zzy6e15LwPPqrD_nQKUDg</recordid><startdate>20141130</startdate><enddate>20141130</enddate><creator>Liu, Yi Lun</creator><creator>Lai, Fritz</creator><creator>Wilmott, James S</creator><creator>Yan, Xu Guang</creator><creator>Liu, Xiao Ying</creator><creator>Luan, Qi</creator><creator>Guo, Su Tang</creator><creator>Jiang, Chen Chen</creator><creator>Tseng, Hsin-Yi</creator><creator>Scolyer, Richard A</creator><creator>Jin, Lei</creator><creator>Zhang, Xu Dong</creator><general>Impact Journals LLC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20141130</creationdate><title>Noxa upregulation by oncogenic activation of MEK/ERK through CREB promotes autophagy in human melanoma cells</title><author>Liu, Yi Lun ; Lai, Fritz ; Wilmott, James S ; Yan, Xu Guang ; Liu, Xiao Ying ; Luan, Qi ; Guo, Su Tang ; Jiang, Chen Chen ; Tseng, Hsin-Yi ; Scolyer, Richard A ; Jin, Lei ; Zhang, Xu Dong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-80b98b6699cc5427b9eb8ea087decc2fe34c1874ef6553b0cfc55738ae9bc0b73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Autophagy - physiology</topic><topic>Cell Line, Tumor</topic><topic>Extracellular Signal-Regulated MAP Kinases - genetics</topic><topic>Extracellular Signal-Regulated MAP Kinases - metabolism</topic><topic>Humans</topic><topic>MAP Kinase Kinase Kinases - genetics</topic><topic>MAP Kinase Kinase Kinases - metabolism</topic><topic>MAP Kinase Signaling System</topic><topic>Melanocytes - enzymology</topic><topic>Melanocytes - metabolism</topic><topic>Melanocytes - pathology</topic><topic>Melanoma - enzymology</topic><topic>Melanoma - genetics</topic><topic>Melanoma - metabolism</topic><topic>Melanoma - pathology</topic><topic>Proto-Oncogene Proteins c-bcl-2 - genetics</topic><topic>Proto-Oncogene Proteins c-bcl-2 - metabolism</topic><topic>Research Paper</topic><topic>Signal Transduction</topic><topic>Up-Regulation</topic><toplevel>online_resources</toplevel><creatorcontrib>Liu, Yi Lun</creatorcontrib><creatorcontrib>Lai, Fritz</creatorcontrib><creatorcontrib>Wilmott, James S</creatorcontrib><creatorcontrib>Yan, Xu Guang</creatorcontrib><creatorcontrib>Liu, Xiao Ying</creatorcontrib><creatorcontrib>Luan, Qi</creatorcontrib><creatorcontrib>Guo, Su Tang</creatorcontrib><creatorcontrib>Jiang, Chen Chen</creatorcontrib><creatorcontrib>Tseng, Hsin-Yi</creatorcontrib><creatorcontrib>Scolyer, Richard A</creatorcontrib><creatorcontrib>Jin, Lei</creatorcontrib><creatorcontrib>Zhang, Xu Dong</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncotarget</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Yi Lun</au><au>Lai, Fritz</au><au>Wilmott, James S</au><au>Yan, Xu Guang</au><au>Liu, Xiao Ying</au><au>Luan, Qi</au><au>Guo, Su Tang</au><au>Jiang, Chen Chen</au><au>Tseng, Hsin-Yi</au><au>Scolyer, Richard A</au><au>Jin, Lei</au><au>Zhang, Xu Dong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Noxa upregulation by oncogenic activation of MEK/ERK through CREB promotes autophagy in human melanoma cells</atitle><jtitle>Oncotarget</jtitle><addtitle>Oncotarget</addtitle><date>2014-11-30</date><risdate>2014</risdate><volume>5</volume><issue>22</issue><spage>11237</spage><epage>11251</epage><pages>11237-11251</pages><issn>1949-2553</issn><eissn>1949-2553</eissn><abstract>Reduction in the expression of the anti-survival BH3-only proteins PUMA and Bim is associated with the pathogenesis of melanoma. However, we have found that the expression of the other BH3-only protein Noxa is commonly upregulated in melanoma cells, and that this is driven by oncogenic activation of MEK/ERK. Immunohistochemistry studies showed that Noxa was expressed at higher levels in melanomas than nevi. Moreover, the expression of Noxa was increased in metastatic compared to primary melanomas, and in thick primaries compared to thin primaries. Inhibition of oncogenic BRAFV600E or MEK downregulated Noxa, whereas activation of MEK/ERK caused its upregulation. In addition, introduction of BRAFV600E increased Noxa expression in melanocytes. Upregulation of Noxa was due to a transcriptional increase mediated by cAMP responsive element binding protein, activation of which was also increased by MEK/ERK signaling in melanoma cells. Significantly, Noxa appeared necessary for constitutive activation of autophagy, albeit at low levels, by MEK/ERK in melanoma cells. Furthermore, it was required for autophagy activation that delayed apoptosis in melanoma cells undergoing nutrient deprivation. These results reveal that oncogenic activation of MEK/ERK drives Noxa expression to promote autophagy, and suggest that Noxa has an indirect anti-apoptosis role in melanoma cells under nutrient starvation conditions.</abstract><cop>United States</cop><pub>Impact Journals LLC</pub><pmid>25365078</pmid><doi>10.18632/oncotarget.2616</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1949-2553 |
ispartof | Oncotarget, 2014-11, Vol.5 (22), p.11237-11251 |
issn | 1949-2553 1949-2553 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4294377 |
source | PubMed Central (PMC) |
subjects | Autophagy - physiology Cell Line, Tumor Extracellular Signal-Regulated MAP Kinases - genetics Extracellular Signal-Regulated MAP Kinases - metabolism Humans MAP Kinase Kinase Kinases - genetics MAP Kinase Kinase Kinases - metabolism MAP Kinase Signaling System Melanocytes - enzymology Melanocytes - metabolism Melanocytes - pathology Melanoma - enzymology Melanoma - genetics Melanoma - metabolism Melanoma - pathology Proto-Oncogene Proteins c-bcl-2 - genetics Proto-Oncogene Proteins c-bcl-2 - metabolism Research Paper Signal Transduction Up-Regulation |
title | Noxa upregulation by oncogenic activation of MEK/ERK through CREB promotes autophagy in human melanoma cells |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T09%3A50%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Noxa%20upregulation%20by%20oncogenic%20activation%20of%20MEK/ERK%20through%20CREB%20promotes%20autophagy%20in%20human%20melanoma%20cells&rft.jtitle=Oncotarget&rft.au=Liu,%20Yi%20Lun&rft.date=2014-11-30&rft.volume=5&rft.issue=22&rft.spage=11237&rft.epage=11251&rft.pages=11237-11251&rft.issn=1949-2553&rft.eissn=1949-2553&rft_id=info:doi/10.18632/oncotarget.2616&rft_dat=%3Cproquest_pubme%3E1639496843%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c462t-80b98b6699cc5427b9eb8ea087decc2fe34c1874ef6553b0cfc55738ae9bc0b73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1639496843&rft_id=info:pmid/25365078&rfr_iscdi=true |